CRYOPORT, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
CRYOPORT, INC. (CYRX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $8.80 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2024-11-07
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $8.80M.
- 2024-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $11.00M.
- 2015-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $8.80M.
- 2015-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.40M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2024-09-30 | $8.80M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $11.00M 10-Q · filed 2024-08-08 |
| 2015-12-31 | $8.80M 10-Q · filed 2016-02-11 |
| 2015-09-30 | $6.40M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $7.00M 10-Q · filed 2015-08-06 |
| 2013-12-31 | $1.80M 10-Q · filed 2014-02-13 |
| 2013-09-30 | $1.99M 10-Q · filed 2013-11-18 |
| 2013-06-30 | $2.03M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $425.09K 10-K · filed 2013-06-25 |
| 2012-12-31 | $576.88K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $478.17K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $366.09K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |